Frovatriptan as a Transitional Therapy in Medication Overuse Headache
Status:
Completed
Trial end date:
2019-04-17
Target enrollment:
Participant gender:
Summary
This study will analyze the effectiveness of a medication called Frovatriptan, in the context
of medication overuse headache (MOH). MOH is a headache that develops when pain-killers are
taken frequently. The treatment is to stop the overuse of these pain-killers, but that can
sometimes worsen the headache first before it gets better. We are testing Frovatriptan
against placebo to see if it can help patients with this transition and avoid the worsening
of the headache that can occur. We will also see if Frovatriptan can help in other ways, such
as maintain patients free of medication overuse.